Expression of Caspase 14 and Filaggrin in Oral Squamous Carcinoma

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2013 May 7

PMID 23645350

Citations 4

Authors

Constance Scharenberg

Andre Eckardt

Christina Tiede

Hans Kreipe

Kais Hussein

Affiliations

Soon will be listed here.

Abstract

Caspase 14 is one of the latter discovered members of the caspase enzyme family and, although sharing sequence homologies with the other caspases, it is not involved in apoptosis. Together with its co-factor filaggrin, it plays an important role in skin barrier formation. It is already known that caspase 14 proteins are reduced during neoplastic dedifferentiation in cervical intraepithelial neoplasms and in invasive cervical carcinomas. Oral squamous carcinoma tissues have not been systematically evaluated for caspase 14 expression yet. Formalin-fixed and paraffin-embedded samples from oral squamous carcinomas (n = 36 tumours from 34 patients), metastases (n = 15) and controls (leukoplakia, n = 10) were analysed by immunohistochemistry. In carcinomas, human papilloma virus (HPV) infection was tested by PCR. Here we demonstrate that, in oral epithelia, caspase 14 is expressed mainly by cells of the intermediate and superficial cell layers while filaggrin is expressed only in keratinising foci in leukoplakia. Caspase 14 and filaggrin are co-localised. In invasive oral carcinomas, reduced expression of caspase 14 was detectable in 47 % of tumours but was not associated with keratinisation, tumour differentiation or HPV infection. Filaggrin was detectable in a subfraction of tumours (56 %) and was restricted to keratinising areas of the carcinomas. In summary, in contrast to cervical carcinomas, partial loss of caspase 14 is not associated with dedifferentiation in neoplastic lesions of the oral mucosa or HPV infection.

Citing Articles

Gibberellic Acid Initiates ER Stress and Activation of Differentiation in Cultured Human Immortalized Keratinocytes HaCaT and Epidermoid Carcinoma Cells A431.

Vildanova M, Vishnyakova P, Saidova A, Konduktorova V, Onishchenko G, Smirnova E Pharmaceutics. 2021; 13(11).

PMID: 34834228 PMC: 8622727. DOI: 10.3390/pharmaceutics13111813.

Caspase-14-From Biomolecular Basics to Clinical Approach. A Review of Available Data.

Markiewicz A, Sigorski D, Markiewicz M, Owczarczyk-Saczonek A, Placek W Int J Mol Sci. 2021; 22(11).

PMID: 34070382 PMC: 8197544. DOI: 10.3390/ijms22115575.

Genome-wide gene expression profiling of tongue squamous cell carcinoma by RNA-seq.

Zhang H, Liu O, Deng C, He Y, Feng Y, Ma J Clin Oral Investig. 2017; 22(1):209-216.

PMID: 28357642 DOI: 10.1007/s00784-017-2101-7.

Expression of cyclin-dependent kinase inhibitor 2A 16, tumour protein 53 and epidermal growth factor receptor in salivary gland carcinomas is not associated with oncogenic virus infection.

Senft E, Lemound J, Stucki-Koch A, Gellrich N, Kreipe H, Hussein K Int J Oral Sci. 2014; 7(1):18-22.

PMID: 25012870 PMC: 4817540. DOI: 10.1038/ijos.2014.28.

References

Grosso M, Lentini M, Bellizi De Marco E, Petracca R, Leoncini P, CARROZZA G . Immunohistochemical localization of filaggrin in benign and malignant lesions of the human oral mucosa. Basic Appl Histochem. 1990; 34(1):51-8. View

Kristoffersen A, Enersen M, Kverndokk E, Sunde P, Landin M, Solheim T . Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa. J Clin Virol. 2012; 53(4):364-6. DOI: 10.1016/j.jcv.2011.12.023. View

Denecker G, Ovaere P, Vandenabeele P, Declercq W . Caspase-14 reveals its secrets. J Cell Biol. 2008; 180(3):451-8. PMC: 2234247. DOI: 10.1083/jcb.200709098. View

Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S . Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol. 2007; 9(6):666-74. DOI: 10.1038/ncb1597. View

Bayo P, Sanchis A, Bravo A, Cascallana J, Buder K, Tuckermann J . Glucocorticoid receptor is required for skin barrier competence. Endocrinology. 2007; 149(3):1377-88. DOI: 10.1210/en.2007-0814. View

van de Craen M, van Loo G, Pype S, Van Criekinge W, Van den brande I, Molemans F . Identification of a new caspase homologue: caspase-14. Cell Death Differ. 1999; 5(10):838-46. DOI: 10.1038/sj.cdd.4400444. View

Bockmeyer C, Maegel L, Janciauskiene S, Rische J, Lehmann U, Maus U . Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant. 2012; 31(7):764-72. DOI: 10.1016/j.healun.2012.03.010. View

Hsu S, Qin H, Dickinson D, Xie D, Bollag W, Stoppler H . Expression of caspase-14 reduces tumorigenicity of skin cancer cells. In Vivo. 2007; 21(2):279-83. View

Aho S, Harding C, Lee J, Meldrum H, Bosko C . Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis. J Invest Dermatol. 2012; 132(10):2376-2385. DOI: 10.1038/jid.2012.174. View

10.

Ballaun C, Karner S, Mrass P, Mildner M, Buchberger M, Bach J . Transcription of the caspase-14 gene in human epidermal keratinocytes requires AP-1 and NFkappaB. Biochem Biophys Res Commun. 2008; 371(2):261-6. DOI: 10.1016/j.bbrc.2008.04.050. View

11.

Hsu S, Yamamoto T, Borke J, Walsh D, Singh B, Rao S . Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. J Pharmacol Exp Ther. 2004; 312(3):884-90. DOI: 10.1124/jpet.104.076075. View

12.

Lippens S, Kockx M, Denecker G, Knaapen M, Verheyen A, Christiaen R . Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. Am J Pathol. 2004; 165(3):833-41. PMC: 1618612. DOI: 10.1016/S0002-9440(10)63346-9. View

13.

Kuechle M, Predd H, Fleckman P, Dale B, Presland R . Caspase-14, a keratinocyte specific caspase: mRNA splice variants and expression pattern in embryonic and adult mouse. Cell Death Differ. 2001; 8(8):868-70. DOI: 10.1038/sj.cdd.4400897. View

14.

Lara C, Serra V, Marzo C, Valcuende F, Castells A, Bonilla-Musoles F . Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue. Arch Gynecol Obstet. 1994; 255(2):73-9. DOI: 10.1007/BF02391801. View

15.

Pilatz A, Altinkilic B, Rusz A, Izykowski N, Traenkenschuh W, Rische J . Role of human papillomaviruses in persistent and glucocorticoid-resistant juvenile phimosis. J Eur Acad Dermatol Venereol. 2012; 27(6):716-21. DOI: 10.1111/j.1468-3083.2012.04542.x. View

16.

Raymond A, Mechin M, Nachat R, Toulza E, Tazi-Ahnini R, Serre G . Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol. 2007; 156(3):420-7. DOI: 10.1111/j.1365-2133.2006.07656.x. View

17.

Yamamoto M, Kamata Y, Iida T, Fukushima H, Nomura J, Saito M . Quantification of activated and total caspase-14 with newly developed ELISA systems in normal and atopic skin. J Dermatol Sci. 2010; 61(2):110-7. DOI: 10.1016/j.jdermsci.2010.11.018. View

18.

Turatti E, Neves A, de Magalhaes M, de Sousa S . Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. J Oral Sci. 2005; 47(2):71-6. DOI: 10.2334/josnusd.47.71. View

19.

Yoo N, Soung Y, Lee S, Jeong E, Lee S . Mutational analysis of caspase-14 gene in common carcinomas. Pathology. 2007; 39(3):330-3. DOI: 10.1080/00313020701329815. View

20.

Nakayama H, Ikebe T, Beppu M, Shirasuna K . High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer. 2001; 92(12):3037-44. DOI: 10.1002/1097-0142(20011215)92:12<3037::aid-cncr10171>3.0.co;2-#. View